HomeNewsBusinessManipal-TPG revises Fortis valuation to Rs 8,358 crore, says will invest Rs 2,100 crore upfront

Manipal-TPG revises Fortis valuation to Rs 8,358 crore, says will invest Rs 2,100 crore upfront

Manipal and TPG together will be investing around Rs 3,300 crore​ in the deal for Fortis Healthcare.

May 07, 2018 / 10:13 IST
Story continues below Advertisement

Viswanath Pilla Moneycontrol News

This article has been updated to reflect changes to the afore-mentioned particulars of Manipal-TPG's latest offer.

The Manipal-TPG consortium on Sunday made a revised offer for Fortis Healthcare, valuing the company at Rs 8,358 crore, or Rs 160 per share, and said it will invest Rs 2,100 crore upfront in the healthcare services provider as a part of the deal.

Story continues below Advertisement

Manipal and TPG together will be investing around Rs 3,300 crore​ in the deal for Fortis Healthcare, of which Rs 2,100 crore will be invested in the company and Rs 1,200 crore will be used to buy private equity investors’ stake in SRL Diagnostics.

The consortium offered to buy the 30.93 percent stake held by private equity firms in SRL Diagnostics at a price that values the Fortis subsidiary at Rs 3,600 crore.